[Trial of adriamycin in the treatment of acute leukemia].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000606:Amino Sugars / Q000627:therapeutic use; D000880:Anthraquinones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D002675:Child, Preschool; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000606:Amino Sugars; D000880:Anthraquinones; D000900:Anti-Bacterial Agents; D003630:Daunorubicin
Essai de l'adriamycine dans le traitement des leucémies aiguës.